To Vaccinate or not: Influenza Virus and Lung Cancer Progression.
Trends Cancer 2021;
7:573-576. [PMID:
33712391 DOI:
10.1016/j.trecan.2021.02.006]
[Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/03/2020] [Revised: 02/18/2021] [Accepted: 02/19/2021] [Indexed: 11/22/2022]
Abstract
Influenza virus infection leads to severe and complicated disease, particularly in patients with lung cancer. It alters the tumor microenvironment (TME), which may potentiate lung cancer progression and disrupt responses to antitumoral treatments. Consequently, influenza vaccination and antiviral treatments should be recommended to all patients with lung cancer.
Collapse